Holly Watson

Doctor of Osteopathic Medicine,  Massachusetts General Hospital 

Location: Germany

Consulting Services

Research Consulting Data Science-Bioinformatics Admin and Customer Support Biostatistics

Areas Of Interest

Chronic Granulocytic Leukemia Valerians Primary Night Terrors Trismus Site, Combining Pseudotumor, Orbital Auditory Pathways Manduca sexta guajava, Psidium Microprolactinomas Soluble Lymphotoxin-alpha Programs, Employee Orientation Elastase, Neutrophil Interfaces, Bone-Implant NAD-Dependent Glyceraldehyde-3-phosphate Dehydrogenase Ornithine 2 Ketoglutarate Aminotransferase Hensen Node Cyclic Nucleotide Gated Cation Channels Glial Cell, Radial Hyperlipoproteinemias, Type III Behavior, Criminal Measurement, Epidemiologic Hygienists, Dental Microchip, DNA rap GTP-Binding Proteins Anecdotes Losses, Hair Heat Avoidance Encephalomyelitis Virus, Western Equine Cystic Renal Disease Biperiden, 1R-(1 alpha,2 alpha(R*),4 alpha)-Isomer Calcium Calmodulin Dependent Protein Kinase Type 1 beta Isoform Pursuits, Saccadic Lettuces, Water Tinnitus, Tensor Tympani Induced Profilin CYP2C19 Inhibitors Activator 1 Protein, 145 kDa Subunit

Professional Narrative

Dr. Holly Watson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Watson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Assistant Professor, Harvard Med 1987
Executive Director, Mayo Clinic 1990

Education

Doctor of osteopathic medicine, Weill Medical College 1999
Bachelor of science in nursing, Harvard Medical School 2007

Referees


Publications

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :